ABSTRACT
Risperidone is an often-preferred molecule for target symptoms in autism spectrum disorder (ASD) patients. Although generally well tolerated, its widespread use in children and adolescents entails the risk of overdose in some cases, intentionally or unintentionally. Pediatric cases related to this issue are rare but can be severe. In this article, a nine year old patient diagnosed with ASD, who was brought to the emergency after unintentionally ingesting high-dose risperidone drug (100 mg), is presented. As far as our can knowledge in the literature, our case is the second highest dose of acute risperidone ingestion seen in a pediatric case.
References
1
Lord C, Elsabbagh M, Baird G, Veenstra-Vanderweele J. Autism Spectrum Disorder. Lancet. 2018;392:508-520.
2
Masi A, DeMayo MM, Glozier N, Guastella AJ. An Overview of Autism Spectrum Disorder, Heterogeneity and Treatment Options. Neurosci Bull. 2017;33:183-193.
3
DeFilippis M, Wagner KD. Treatment of Autism Spectrum Disorder in Children and Adolescents Psychopharmacol Bull. 2016;46:18-41.
4
Luby J, Mrakotsky C, Stalets MM, Belden A, Heffelfinger A, Williams M, Spitznagel E. Risperidone in Preschool Children with Autistic Spectrum Disorders: An Investigation of Safety and Efficacy. J Child Adolesc Psychopharmacol. 2006;16:575-587.
5
Anita SX, Sholevar EH, Baron DA. Overdoses and Ingestions of Second-Generation Antipsychotics in Children and Adolescents. J Child Adolesc Psychopharmacol. 2005;15:970-985.
6
Burns MJ. The Pharmacology and Toxicology of Atypical Antipsychotic Agents, J Toxicol Clin Toxicol. 2001;39:1-14.
7
Stassinos G, Klein-Schwartz W. Comparison of Pediatric Atypical Antipsychotic Exposures Reported to U.S. Poison Centers. Clin Toxicol (Phila). 2017;55:40-45.
8
Shafiq S, Pringsheim T. Using Antipsychotics for Behavioral Problems in Children. Expert Opin Pharmacother. 2018;19:1475-1488.
9
Karaca S, Özatalay E, Canan F. A Case of Risperidone Overdose in a 4 Year Old Boy. Prim Care Companion CNS Disord. 2016;18:10.4088/PCC.15l01855.
10
Bishara D, Taylor D. Upcoming Agents for The Treatment of Schizophrenia: Mechanism of Action, Efficacy and Tolerability. Drugs. 2008;68:2269-2292.
11
Catalano G, Catalano MC, Nunez CY, Walker SC. Atypical Antipsychotic Overdose in the Pediatric Population. J Child Adolesc Psychopharmacol. 2001;11:425-434.
12
Page CB, Calver LA, Isbister GK. Risperidone Overdose Causes Extrapyramidal Effects But Not Cardiac Toxicity. J Clin Psychopharmacol. 2010;30:387-390.
13
Meli M, Rauber-Lüthy C, Hoffmann-Walbeck P, Reinecke HJ, Prasa D, Stedtler U, Färber E, Genser D, Kupferschmidt H, Kullak-Ublick GA, Ceschi A. Atypical Antipsychotic Poisoning in Young Children: A Multicentre Analysis of Poisons Centres Data. Eur J Pediatr. 2014;173:743-750.
14
Cheslik TA, Erramouspe J. Extrapyramidal Symptoms Following Accidental İngestion of Risperidone in a Child. Ann Pharmacother. 1996;30:360-363.
15
Aslan S, Dalkara T, Herken H, İşeri E, Koçak EE, Rezaki M, Sayın A, Şenol S, Uzbay T, Yetkin S, Yüksel N, Zengil H. Antipsikotik İlaçlar. In: Yüksel N eds. Psikofarmakoloji. Ankara; Nobel Tıp Yayınevi. 2007:47-143
16
Göktalay G. Antipsikotik İlaçlar. In: Stahl SM, Uzbay T, eds. Stahl’ın Temel Psikofarmakolojisi. İstanbul; İstanbul Medikal Yayıncılık. 2021:327-451.
17
Loonen AJ, Ivanova SA. Neurobiological mechanisms associated with antipsychotic drug-induced dystonia. J Psychopharmacol. 2021;35:3-14.